Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
MBOT similar filings
- 16 Dec 16 Microbot Medical Inc. Announces First Investor Briefing Conference Call and Webcast
- 8 Dec 16 Microbot Medical Appoints Hezi Himelfarb as General Manager and Chief Operating Officer
- 2 Dec 16 Microbot Medical Closes Asset Sale; Proceeds will be Used to Further Develop its
- 29 Nov 16 Changes in Registrant's Certifying Accountant
- 15 Nov 16 Entry into a Material Definitive Agreement
- 27 Oct 16 Four of Five Proposals Approved at Company’s 2016 Special Stockholder Meeting
- 2 Sep 16 Other Events
Filing view
External links
Exhibit 16.1
November 29, 2016
U.S. Securities and Exchange Commission Office of the Chief Accountant 100 F Street, NE Washington, DC 20549 | Grant Thornton LLP 101 California Street, Suite 2700 San Francisco, CA 94111
T 415.986.3900 F 415.986.3916 www.GrantThornton.com | |
Re: | Microbot Medical Inc. |
File No. 000-19871
Dear Sir or Madam:
We have read Item 4.01 of Form 8-K of Microbot Medical Inc. dated November 29, 2016, and agree with the statements concerning our Firm contained therein.
Very truly yours,
Grant Thornton LLP
U.S. member firm of Grant Thornton International Ltd